The joint CVS Health/IBM Watson Health solution will be optimized for use across a wide range of chronic conditions. Chronic diseases such as hypertension, heart disease, diabetes, and obesity are the leading cause of death and disability in the U.S. and represent 86 percent of the nation's $2.9 trillion in annual health spending. The resulting offering will be made available to insurers and other entities serving the employer and health plan market and will focus on:
The partnership brings together IBM's Watson Health Cloud and cognitive computing capabilities with both companies' expertise in predictive analytics and patient engagement. CVS Health also brings strong insights into medication adherence and pharmacy care.
"CVS Health and IBM are both committed to improving health and finding ways to engage individuals in their well-being through the use of information and technology", stated Troyen A. Brennan, MD, EVP and Chief Medical Officer for CVS Health. "This partnership will enable us to leverage advanced technologies and key health information to develop a tool that can be applied by a variety of health care providers such as pharmacists, nurse practitioners at MinuteClinics or connected health care providers, and that can help our pharmacy benefit management clients improve member health and manage cost."
"The capabilities of the IBM Watson Health Cloud, when coupled with CVS Health's insights into medication utilization and patient behaviour, could prove transformative for the industry", stated Mike Rhodin, senior vice president, IBM Watson. "Improving care for people with chronic conditions supports IBM's commitment to make big plays that advance the health and well-being of the global community. Through the recent acquisitions of Phytel, Explorys, and Curam we also bring extraordinary capabilities in patient engagement and population health, enabling us to deliver a powerful solution that supports individuals wherever they are, whenever they need it."